20 May 2013
Keywords: sciclone, phase, iii, trials, mexico, pharmaceuticals, thymosin
Article | 25 January 1993
- SciClone Pharmaceuticals' thymosin alpha 1, a treatment for hepatitis B infection, has reportedly entered Phase III trials in Mexico.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.